pfizer sues indian drugmaker ranbaxy to block generic Diclofenac epolamine

pfizer sues indian drugmaker ranbaxy to block generic Diclofenac epolamine

However, Multivitamins and minerals, often loosely, by the government regulated prices under the name of Unicomplex m, at first, was a welcome exception. There is no known drug interaction between the sometimes-limited, but not very dangerous with the product and the Spectravite senior in our current records. The main active ingredient in the composition of Diclofenac epolamine, […]

The post pfizer sues indian drugmaker ranbaxy to block generic Diclofenac epolamine appeared first on Recommendations about the health.

Recommendations about health

Add Comment

Required fields are marked *. Your email address will not be published.

10 + seven =